Observational studyPloS one2020

Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.

Hung-Jen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.